$3.32 Billion is the total value of Nantahala Capital Management's 130 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $587,038,000 | +14.0% | 4,100,000 | -8.9% | 17.70% | -8.2% |
| W | Buy | WAYFAIR INCcall | $257,684,000 | +333.1% | 1,304,000 | +17.1% | 7.77% | +248.8% |
| CVNA | Sell | CARVANA COcall | $216,649,000 | +115.4% | 1,802,400 | -1.3% | 6.53% | +73.4% |
| IWM | Sell | ISHARES TRcall | $171,816,000 | -46.4% | 1,200,000 | -57.1% | 5.18% | -56.8% |
| SPY | New | SPDR S&P 500 ETF TRput | $123,344,000 | – | 400,000 | +100.0% | 3.72% | – |
| HYG | Sell | ISHARES TRput | $97,944,000 | -49.2% | 1,200,000 | -52.0% | 2.95% | -59.1% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $82,853,000 | +66.6% | 6,101,111 | -7.0% | 2.50% | +34.2% |
| QURE | Sell | UNIQURE NV | $70,661,000 | -12.9% | 1,568,149 | -8.3% | 2.13% | -29.9% |
| SGMS | Sell | SCIENTIFIC GAMES CORPcall | $66,921,000 | +47.5% | 4,328,600 | -7.5% | 2.02% | +18.7% |
| DLB | Buy | DOLBY LABORATORIES INC | $61,272,000 | +35.1% | 930,193 | +11.2% | 1.85% | +8.8% |
| CDXS | CODEXIS INC | $61,144,000 | +2.2% | 5,363,484 | 0.0% | 1.84% | -17.8% | |
| CUE | Sell | CUE BIOPHARMA INC | $56,995,000 | +60.4% | 2,325,388 | -7.1% | 1.72% | +29.2% |
| VG | Buy | VONAGE HLDGS CORP | $51,641,000 | +65.3% | 5,133,300 | +18.8% | 1.56% | +33.1% |
| QADA | QAD INCcl a | $48,457,000 | +3.4% | 1,173,868 | 0.0% | 1.46% | -16.8% | |
| QURE | Buy | UNIQURE NVcall | $47,876,000 | +10.6% | 1,062,500 | +16.4% | 1.44% | -11.0% |
| VAC | Sell | MARRIOTT VACTINS WORLDWID CO | $44,528,000 | -17.0% | 541,633 | -43.9% | 1.34% | -33.2% |
| THC | TENET HEALTHCARE CORPcall | $43,510,000 | +25.8% | 2,402,500 | 0.0% | 1.31% | +1.2% | |
| THC | Buy | TENET HEALTHCARE CORP | $40,659,000 | +32.5% | 2,245,124 | +5.3% | 1.23% | +6.7% |
| RH | Sell | RH | $39,306,000 | -18.2% | 157,920 | -67.0% | 1.18% | -34.1% |
| KRE | SPDR SER TRput | $38,390,000 | +17.8% | 1,000,000 | 0.0% | 1.16% | -5.2% | |
| MED | MEDIFAST INC | $37,878,000 | +122.0% | 272,957 | 0.0% | 1.14% | +78.7% | |
| Sell | APTOSE BIOSCIENCES INC | $37,714,000 | +0.8% | 5,976,852 | -5.1% | 1.14% | -18.8% | |
| IMXI | Buy | INTERNATIONAL MNY EXPRESS IN | $36,292,000 | +36.8% | 2,912,690 | +0.2% | 1.09% | +10.1% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $35,636,000 | +28.1% | 1,907,713 | -0.9% | 1.08% | +3.2% |
| CAR | New | AVIS BUDGET GROUPput | $34,335,000 | – | 1,500,000 | +100.0% | 1.04% | – |
| IWM | New | ISHARES TRrussell 2000 etf | $33,586,000 | – | 234,569 | +100.0% | 1.01% | – |
| CASH | META FINL GROUP INC | $32,701,000 | -16.3% | 1,799,727 | 0.0% | 0.99% | -32.7% | |
| LXFR | Sell | LUXFER HOLDINGS PLC | $31,887,000 | -7.3% | 2,253,472 | -7.4% | 0.96% | -25.3% |
| DXPE | Sell | DXP ENTERPRISES INC NEW | $31,846,000 | +62.1% | 1,599,482 | -0.2% | 0.96% | +30.4% |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $29,645,000 | +126.2% | 3,204,830 | +12.4% | 0.89% | +82.1% |
| HCA | Sell | HCA HEALTHCARE INC | $28,827,000 | +0.4% | 296,999 | -7.0% | 0.87% | -19.2% |
| WYND | Buy | WYNDHAM DESTINATIONS INC | $28,009,000 | +86.9% | 993,939 | +43.9% | 0.84% | +50.6% |
| TBBK | Sell | BANCORP INC DEL | $25,715,000 | +57.8% | 2,623,939 | -2.2% | 0.78% | +27.0% |
| FRG | Sell | FRANCHISE GROUP INC | $25,336,000 | +52.1% | 1,157,965 | -39.4% | 0.76% | +22.4% |
| WRLD | Buy | WORLD ACCEP CORP DEL | $24,273,000 | +21.1% | 370,469 | +0.9% | 0.73% | -2.5% |
| BDSI | BIODELIVERY SCIENCES INTL IN | $21,816,000 | +15.0% | 5,003,631 | 0.0% | 0.66% | -7.3% | |
| SCPL | Buy | SCIPLAY CORPcl a | $20,243,000 | +112.3% | 1,365,032 | +36.4% | 0.61% | +70.9% |
| GDEN | Sell | GOLDEN ENTMT INC | $18,980,000 | +17.2% | 2,127,788 | -13.1% | 0.57% | -5.6% |
| ALTG | Buy | ALTA EQUIPMENT GROUP INC | $18,927,000 | +83.9% | 2,435,887 | +1.0% | 0.57% | +47.9% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $18,193,000 | +99.2% | 1,747,679 | +79.3% | 0.55% | +60.5% |
| UPLD | Buy | UPLAND SOFTWARE INC | $18,212,000 | +31.3% | 523,946 | +1.3% | 0.55% | +5.6% |
| ARYA | Buy | ARYA SCIENCES ACQUISITION CO | $17,504,000 | +189.9% | 1,112,087 | +99.8% | 0.53% | +133.6% |
| PTON | PELOTON INTERACTIVE INC | $17,331,000 | +117.6% | 300,000 | 0.0% | 0.52% | +75.5% | |
| PAR | Sell | PAR TECHNOLOGY CORP | $16,687,000 | +93.2% | 557,528 | -17.0% | 0.50% | +55.7% |
| SLNO | Buy | SOLENO THERAPEUTICS INC | $16,487,000 | +61.9% | 7,426,368 | +73.6% | 0.50% | +30.4% |
| CAR | AVIS BUDGET GROUPcall | $15,055,000 | +64.7% | 657,700 | 0.0% | 0.45% | +32.7% | |
| CERC | New | CERECOR INC | $14,772,000 | – | 5,681,404 | +100.0% | 0.44% | – |
| HCA | Sell | HCA HEALTHCARE INCput | $14,559,000 | -65.5% | 150,000 | -68.1% | 0.44% | -72.3% |
| INMD | Buy | INMODE LTD | $14,496,000 | +155.9% | 511,856 | +94.3% | 0.44% | +106.1% |
| VMD | VIEMED HEALTHCARE INC | $14,382,000 | +101.7% | 1,498,100 | 0.0% | 0.43% | +62.5% | |
| CRHM | CRH MED CORP | $14,168,000 | +56.3% | 6,777,905 | 0.0% | 0.43% | +26.0% | |
| HAL | Buy | HALLIBURTON COcall | $14,099,000 | +132.3% | 1,086,200 | +22.6% | 0.42% | +87.2% |
| CZR | CAESARS ENTMT CORPcall | $13,260,000 | +492.5% | 331,000 | 0.0% | 0.40% | +376.2% | |
| EXAS | EXACT SCIENCES CORPput | $13,041,000 | +49.9% | 150,000 | 0.0% | 0.39% | +20.6% | |
| JYNT | JOINT CORP | $12,962,000 | +40.7% | 848,881 | 0.0% | 0.39% | +13.3% | |
| AMRS | New | AMYRIS INC | $12,582,000 | – | 1,664,171 | +100.0% | 0.38% | – |
| FTACU | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $12,278,000 | +22.8% | 977,022 | 0.0% | 0.37% | -1.1% | |
| FBIO | Buy | FORTRESS BIOTECH INC | $11,859,000 | +243.1% | 4,424,938 | +142.0% | 0.36% | +177.5% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $10,694,000 | +69.2% | 1,821,749 | +25.9% | 0.32% | +35.9% |
| KROS | New | KEROS THERAPEUTICS INC | $10,315,000 | – | 275,000 | +100.0% | 0.31% | – |
| CATS | Buy | CATASYS INC | $10,323,000 | +245.6% | 417,249 | +112.8% | 0.31% | +177.7% |
| DHX | DHI GROUP INC | $10,163,000 | -0.2% | 4,839,595 | 0.0% | 0.31% | -19.9% | |
| GLMD | Buy | GALMED PHARMACEUTICALS LTD | $9,908,000 | +119.6% | 2,072,745 | +59.0% | 0.30% | +76.9% |
| ARYBU | New | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $9,856,000 | – | 850,000 | +100.0% | 0.30% | – |
| LINC | LINCOLN EDL SVCS CORP | $9,504,000 | +77.3% | 2,436,805 | 0.0% | 0.29% | +42.8% | |
| SGMS | Sell | SCIENTIFIC GAMES CORP | $9,227,000 | -35.8% | 596,834 | -59.7% | 0.28% | -48.4% |
| PENN | PENN NATL GAMING INCput | $9,162,000 | +141.4% | 300,000 | 0.0% | 0.28% | +94.4% | |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $8,920,000 | -38.5% | 533,788 | -46.9% | 0.27% | -50.5% |
| XELA | Sell | EXELA TECHNOLOGIES INC | $8,751,000 | +53.7% | 15,790,720 | -43.2% | 0.26% | +23.9% |
| ARYAU | New | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $8,352,000 | – | 452,944 | +100.0% | 0.25% | – |
| ZVO | ZOVIO INC | $8,118,000 | +85.4% | 2,653,087 | 0.0% | 0.24% | +49.4% | |
| INSUU | INSURANCE ACQUISITION CORPunit 03/31/2024 | $7,500,000 | +44.5% | 500,000 | 0.0% | 0.23% | +16.5% | |
| SIC | Sell | SELECT INTERIOR CONCEPTS INCcl a | $7,136,000 | +60.6% | 2,038,767 | -5.0% | 0.22% | +29.5% |
| SIGA | Sell | SIGA TECHNOLOGIES INC | $6,947,000 | -19.6% | 1,175,438 | -35.0% | 0.21% | -35.5% |
| RFL | Sell | RAFAEL HLDGS INC | $6,763,000 | +10.9% | 470,604 | -3.0% | 0.20% | -10.5% |
| RDI | New | READING INTERNATIONAL INCcl a | $6,650,000 | – | 1,564,634 | +100.0% | 0.20% | – |
| Buy | FALCON MINERALS CORP | $6,386,000 | +52.8% | 1,995,603 | +2.6% | 0.19% | +22.9% | |
| TORC | New | RESTORBIO INC | $6,249,000 | – | 2,906,340 | +100.0% | 0.19% | – |
| SRL | SCULLY ROYALTY LTD | $5,730,000 | +0.9% | 753,885 | 0.0% | 0.17% | -18.8% | |
| GEENQ | New | GLOBAL EAGLE ENTMT INC | $5,504,000 | – | 1,161,255 | +100.0% | 0.17% | – |
| NATR | NATURES SUNSHINE PRODS INC | $5,382,000 | +10.8% | 597,310 | 0.0% | 0.16% | -11.0% | |
| SSKN | Buy | STRATA SKIN SCIENCES INC | $5,388,000 | +74.5% | 4,685,062 | +44.1% | 0.16% | +39.7% |
| TA | TRAVELCENTERS OF AMERICA INC | $5,196,000 | +57.6% | 337,390 | 0.0% | 0.16% | +26.6% | |
| DMAC | DIAMEDICA THERAPEUTICS INC | $5,198,000 | +142.8% | 750,000 | 0.0% | 0.16% | +96.2% | |
| EVRI | New | EVERI HLDGS INC | $5,174,000 | – | 1,002,648 | +100.0% | 0.16% | – |
| TFFP | Buy | TFF PHARMACEUTICALS INC | $4,934,000 | +121.9% | 856,517 | +47.9% | 0.15% | +79.5% |
| RCII | New | RENT A CTR INC NEW | $4,883,000 | – | 175,510 | +100.0% | 0.15% | – |
| AFI | ARMSTRONG FLOORING INC | $4,654,000 | +109.1% | 1,556,435 | 0.0% | 0.14% | +68.7% | |
| STRM | STREAMLINE HEALTH SOLUTIONS | $3,662,000 | +56.4% | 2,753,599 | 0.0% | 0.11% | +25.0% | |
| HTGM | HTG MOLECULAR DIAGNOSTICS IN | $3,643,000 | +121.5% | 5,060,160 | 0.0% | 0.11% | +77.4% | |
| YTRA | New | YATRA ONLINE INC | $3,613,000 | – | 5,320,000 | +100.0% | 0.11% | – |
| ONDK | Sell | ON DECK CAP INC | $3,366,000 | -60.7% | 4,685,269 | -17.2% | 0.10% | -68.2% |
| ACER | ACER THERAPEUTICS INC | $3,398,000 | +72.4% | 990,655 | 0.0% | 0.10% | +37.8% | |
| NEOS | NEOS THERAPEUTICS INC | $3,158,000 | -8.7% | 4,610,000 | 0.0% | 0.10% | -26.9% | |
| EHTH | New | EHEALTH INC | $3,031,000 | – | 30,849 | +100.0% | 0.09% | – |
| APEN | APOLLO ENDOSURGERY INC | $3,023,000 | -14.8% | 1,848,672 | 0.0% | 0.09% | -31.6% | |
| DVD | DOVER MOTORSPORTS INC | $2,628,000 | +24.0% | 1,695,541 | 0.0% | 0.08% | 0.0% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $2,520,000 | -36.5% | 9,566,844 | 0.0% | 0.08% | -49.0% | |
| MACK | MERRIMACK PHARMACEUTICALS IN | $2,490,000 | +54.9% | 747,635 | 0.0% | 0.08% | +25.0% | |
| NNBR | New | NN INC | $1,972,000 | – | 415,988 | +100.0% | 0.06% | – |
| HTZGQ | HERTZ GLOBAL HLDGS INCcall | $1,833,000 | -77.2% | 1,300,000 | 0.0% | 0.06% | -81.7% | |
| NNI | NELNET INCcl a | $1,666,000 | +5.1% | 34,900 | 0.0% | 0.05% | -15.3% | |
| EBIX | EBIX INC | $1,498,000 | +47.3% | 66,997 | 0.0% | 0.04% | +18.4% | |
| DARIOHEALTH CORP | $1,359,000 | -6.5% | 214,091 | 0.0% | 0.04% | -24.1% | ||
| CYRN | New | CYREN LTD | $1,254,000 | – | 1,062,786 | +100.0% | 0.04% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INCput | $1,044,000 | – | 50,000 | +100.0% | 0.03% | – |
| CEMI | Sell | CHEMBIO DIAGNOSTICS INC | $815,000 | -88.9% | 250,793 | -82.5% | 0.02% | -90.9% |
| NK | New | NANTKWEST INC | $614,000 | – | 50,000 | +100.0% | 0.02% | – |
| MOTS | MOTUS GI HLDGS INC | $551,000 | +101.8% | 417,708 | 0.0% | 0.02% | +70.0% | |
| ALTGWS | ALTA EQUIPMENT GROUP INC*w exp 02/14/202 | $580,000 | +84.7% | 187,500 | 0.0% | 0.02% | +41.7% | |
| MDIA | MEDIACO HLDG INCcl a | $515,000 | +28.4% | 98,894 | 0.0% | 0.02% | +6.7% | |
| FALCON MINERALS CORP*w exp 07/21/202 | $282,000 | +19.5% | 878,022 | 0.0% | 0.01% | 0.0% | ||
| CCXI | New | CHEMOCENTRYX INC | $280,000 | – | 4,859 | +100.0% | 0.01% | – |
| CVNA | Sell | CARVANA COcl a | $70,000 | -99.4% | 583 | -99.7% | 0.00% | -99.5% |
| W | Sell | WAYFAIR INCcl a | $32,000 | -100.0% | 164 | -100.0% | 0.00% | -100.0% |
| PHGEU | Exit | BIOMX INCunit 10/16/2024 | $0 | – | -87,299 | -100.0% | -0.02% | – |
| AGS | Exit | PLAYAGS INC | $0 | – | -413,804 | -100.0% | -0.04% | – |
| EMMS | Exit | EMMIS COMMUNICATIONS CORP | $0 | – | -781,783 | -100.0% | -0.06% | – |
| PRTY | Exit | PARTY CITY HOLDCO INC | $0 | – | -7,133,136 | -100.0% | -0.12% | – |
| ENT | Exit | GLOBAL EAGLE ENTMT INC | $0 | – | -29,031,542 | -100.0% | -0.17% | – |
| HTZGQ | Exit | HERTZ GLOBAL HLDGS INC | $0 | – | -849,052 | -100.0% | -0.20% | – |
| CZR | Exit | CAESARS ENTMT CORP | $0 | – | -800,000 | -100.0% | -0.20% | – |
| PLNT | Exit | PLANET FITNESS INCcl a | $0 | – | -152,335 | -100.0% | -0.28% | – |
| WYND | Exit | WYNDHAM DESTINATIONS INCcall | $0 | – | -354,700 | -100.0% | -0.29% | – |
| UAL | Exit | UNITED AIRLS HLDGS INCcall | $0 | – | -500,000 | -100.0% | -0.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.